HEMOSONICS
DUNS: 193921041
# of Employees: 6
HUBZone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Award Charts
Award Listing
-
A Point-of-Care Device for Diagnosis of Platelet Injury in Trauma Patients
Amount: $499,998.00HemoSonics LLC is developing an easy to use and easy to interpret diagnostic device to rapidly identify diffuse coagulopathies in order to guide proper and evidence-based interventions. The management ...
SBIRPhase II2017Department of Defense Defense Health Program -
Development of a POC device to guide efficient use of blood products
Amount: $1,999,325.00DESCRIPTION provided by applicant The Problem The inability of blood to coagulate properly represents a major source of preventable morbidity mortality and unnecessary costs For example over ...
SBIRPhase II2015Department of Health and Human Services -
A Point-of-Care Device for Diagnosis of Platelet Injury in Trauma Patients
Amount: $999,727.00HemoSonics LLC is developing an easy to use and easy to interpret diagnostic device to rapidly identify diffuse coagulopathies in order to guide proper and evidence-based interventions. The management ...
SBIRPhase II2015Department of Defense Defense Health Program -
Assessment of Hypercoagulability in Cancer Patients Using Sonorheometry
Amount: $202,931.00DESCRIPTION (provided by applicant): The Problem: Venous thromboembolism (VTE), which encompasses the diseases of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common and life-threateni ...
SBIRPhase I2014Department of Health and Human Services -
Development of a microfluidic device for the assessment of hemostatic function
Amount: $224,845.00DESCRIPTION (provided by applicant): The monitoring and management of the hemostatic balance in neonatal and pediatric patients remains challenging. Although several conditions/procedures are known to ...
SBIRPhase I2014Department of Health and Human Services -
A Point-of-Care Device for Diagnosis of Platelet Injury in Trauma Patients
Amount: $149,968.00HemoSonics LLC is developing an easy to use and easy to interpret diagnostic device to rapidly identify diffuse coagulopathies in order to guide proper and evidence-based interventions. The management ...
SBIRPhase I2014Defense Health Program Department of Defense -
Development of a point of care diagnostic to guide efficient usage of blood produ
Amount: $2,241,062.00DESCRIPTION (provided by applicant): The Problem: Over 60% of the 600,000 patients undergoing cardio-pulmonary bypass (CPB) procedures in the US each year experience excessive bleeding, which requires ...
SBIRPhase II2013Department of Health and Human Services -
Development of a diagnostic instrument to manage hemostasis in chronic liver dise
Amount: $1,512,209.00DESCRIPTION (provided by applicant): The clinical evaluation and management of hemostasis in the 5 million patients affected by chronic liver diseases (CLD) is poorly understood. Data presented at two ...
SBIRPhase II2011Department of Health and Human Services -
Development of a diagnostic instrument to manage hemostasis in chronic liver dise
Amount: $317,884.00DESCRIPTION (provided by applicant): The clinical evaluation and management of hemostasis in the 5 million patients affected by chronic liver diseases (CLD) is poorly understood. Data presented at two ...
SBIRPhase I2010Department of Health and Human Services -
Development of a point of care diagnostic to guide efficient usage of blood produ
Amount: $298,626.00DESCRIPTION (provided by applicant): Over 60% of the 600,000 patients undergoing cardio-pulmonary bypass (CPB) procedures in the US each year experience intra- and post-operative bleeding. Treatment o ...
SBIRPhase I2010Department of Health and Human Services